WVCTSI releases new RFA for outcomes and policy-related projects
The West Virginia Clinical and Translational Science Institute’s (WVCTSI) Health Outcomes Policy Evaluation (HOPE) Program has received additional funding from the Claude Worthington Benedum Foundation.
This funding, in the amount of $300,000, will allow the HOPE Program to continue its mission of stimulating multi-disciplinary health services and health outcomes assessment endeavors in West Virginia. This will bring the Benedum Foundation’s commitment to the program to $450,000.
Suresh Madhavan, Ph.D., M.B.A., professor in the WVU School of Pharmacy and WVCTSI advisor, and Sally Hodder, M.D., WVCTSI director, will serve as co-investigators for the program, while Usha Sambamoorthi, Ph.D., professor in the WVU School of Pharmacy, has lent her expertise to the initiative.
Funding Opportunity for West Virginia Investigators
As a result of the funding continuance, WVCTSI has released a new Request for Applications (RFA) for demonstration projects under the health outcomes and policy umbrella. Projects should focus on innovative strategies, evidence-based interventions or practices to help improve the quality and effectiveness of healthcare delivery in West Virginia.
The RFA will fund up to three demonstration projects. The maximum performance period is 12 months, and budgets are limited to a maximum of $30,000 in total direct costs. Complete details and instructions regarding the RFA can be found on the WVCTSI website. Applications must be received by 5 p.m. Friday, May 8.
“We remain grateful to the Claude Worthington Benedum Foundation for their continued support of the HOPE Program,” Dr. Hodder said. “This partnership serves as an important mechanism to fill gaps in infrastructure and build capacity to focus on health outcomes and policy evaluation across West Virginia. We look forward to receiving demonstration project applications from our investigators who are really doing outstanding work in this area.”